Innovative Bioresearch
Innovative Bioresearch
About the Company
Our History: The Originator of Decentralized Science (DeSci)
Company Founder
Jonathan Fior
Owner and CEO
Innovative Bioresearch Ltd is a forward-thinking technology company built on a foundation of technical excellence and transparency. The firm operates at the unique intersection of decentralized science (DeSci) and high-performance gaming. Innovative Bioresearch did not launch to follow recent Web3 trends; we created the blueprint for them. Founded and driven by the novel vision of scientist Jonathan Fior, the company established a pioneering asymmetric research model long before the formal emission of the INNBC token in 2018, effectively operating as the global pioneer of Decentralized Science (DeSci). In 2016, Innovative Bioresearch bypassed traditional institutional gatekeepers and centralized pharmaceutical grants. We executed and published the world’s first peer-reviewed in vivo HIV study entirely funded via independent capital generated through early blockchain-space operations, proving that decentralized, self-sustained scientific discovery was possible. The 2018 emission of the INNBC token represented the architectural specialization of this journey. The token was introduced precisely to replace sporadic early blockchain funding with a continuous, programmatic, and decentralized liquidity engine. By route of this evolutionary lineage, the platform seamlessly synthesizes historical, real-world biomedical asset development with state-of-the-art Web3 data integrity frameworks.
Jonathan Fior, born in Los Angeles in 1982 to Italian parents and educated in medical biotechnology at the University of Milan, is a scientist and software developer who shattered the traditional academic-industrial complex. Realizing early on that rigid power dynamics and institutional gatekeepers routinely stifle true innovation, he chose to leverage his advanced programming skills to pioneer a completely autonomous research model: Decentralized Science (DeSci). By utilizing blockchain technology to generate capital on-chain, commissioning physical experiments directly to certified CROs, and securing biomedical data via decentralized architectures, he proved that a single independent researcher with a computer, a connection, and automated AI tools can bypass multi-million dollar university infrastructures and eliminate centralized conflicts of interest. As the founder of Innovative Bioresearch, he effectively created the DeSci framework, executing the world’s first blockchain-funded in vivo study on SupT1 cells as decoy targets for HIV and deploying a biomedical DApp architecture so robust it was published in Springer-Nature and officially cited by Harvard University. Today, his work stands as the ultimate synthesis of computer science and medicine—a sovereign alternative that renders legacy gatekeepers obsolete.
Scientific Publications
Salamander Regeneration as a Model for Developing Novel Regenerative and Anticancer Therapies
What if the secret to defeating cancer and unlocking human regeneration was already written in nature? Among all vertebrates, urodele amphibians possess the near-miraculous ability to perfectly rebuild complex structures throughout their lives. Far from a mere anatomic curiosity, this regenerative process hides a devastating biological weapon: the power to actively reverse tumorigenicity, forcing malignant cancer cells to halt proliferation and return to normal development.
By comparing human cellular mechanics with the dedifferentiating fibroblasts of the salamander, this pioneering review explores radical xenotransplantation studies across species boundaries. When aggressive tumor tissue from frogs is cross-transplanted into the salamander, the host's regenerative blastema accomplishes the impossible: it intercepts the foreign cancer, deconstructs its malignant profile, and reprograms it into healthy, functional muscle and cartilage. This work lays the foundation for a new era of medical science.
SupT1 Cell Infusion as a Possible Cell-Based Therapy for HIV: Results from a Pilot Study in Hu-PBMC BRGS Mice
What if we could defeat HIV by turning its own evolutionary nature into a fatal flaw? In a profound paradigm shift, this study details the in vivo translation of a revolutionary cell-based architecture. Instead of relying on traditional antiretrovirals, the protocol deploys a protective shield of irradiated SupT1 cells engineered to act as master decoys. These cells absorb the viral onslaught, sparing the patient’s native CD4+ T cells from depletion and preventing the onset of AIDS.
But the true genius of the model lies in its evolutionary trap: as HIV replicates within the infused SupT1 cells, it undergoes a natural adaptation that forces it to become significantly less cytopathic and far more sensitive to neutralization—effectively generating a living vaccination effect. By acting as a structural dead-end, this cellular shield delivered an immediate blow in the in vivo trial, slashing plasma viral load by an astonishing 10-fold in the opening week, while leading to complete and total viral suppression in one case, and with zero toxicity in all animal subjects.
INNBC DApp, a decentralized application to permanently store biomedical data on a modern, proof-of-stake (POS), blockchain such as BNB Smart Chain
What if scientific data could be permanently immunized against data tampering, censorship, and institutional gatekeepers? Moving far beyond theoretical Web3 frameworks, this study delivers the real-world operational proof-of-concept for Decentralized Science (DeSci). While legacy platforms merely store a digital fingerprint (hash) on-chain, the INNBC DApp introduces a paradigm shift: a sleek Web3 infrastructure that injects raw text, medical documents, images, audio, and video fully on-chain directly into the transaction layer of a high-performance Proof-of-Stake blockchain.
By executing real-world data uploads of complete peer-reviewed research articles at an optimized cost, this architecture overcomes standard file-size limitations through a multi-volume chunking mechanism, reinforced by military-grade AES encryption for sensitive patient files. By embedding immutability, automated timestamping, and cryptographic proof-of-existence directly into the ledger, the INNBC DApp permanently protects scientific authorship and secures the absolute integrity of global biomedical data, rendering centralized data manipulation obsolete.